Drugs & 
Pill 
Interaction 
Side 
Conditions 
Treatment 
Compare 
My Med 
Discount 
FDA 
Price 
Phonetic 
Health Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Xolremdi (mavorixafor) for Patients with WHIM Syndrome
X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the U.S....
FDA Approves Beqvez (fidanacogene elaparvovec-dzkt) One-Time Gene Therapy for Adults with Hemophilia B
(BUSINESS WIRE) April 26, 2024 -- Pfizer Inc. (NYSE: PFE)announced today that the U.S. Food and Drug Administration (FDA) has approved Beqvez™ (fidanacogene...
FDA Approves Pivya (pivmecillinam) for the Treatment of Uncomplicated Urinary Tract Infections
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract...
Novartis Radioligand Therapy Lutathera FDA Approved as First Medicine Specifically for Pediatric Patients with Gastroenteropancreatic Neuroendocrine Tumors
Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide)...
FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma
Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated...
FDA Approves Anktiva (nogapendekin alfa inbakicept-pmln) Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has approved Anktiva...
Doctors Seeing More Atypical, Severe Symptoms in Patients With Syphilis
Physicians are increasingly seeing cases of syphilis that do not present with typical symptoms, such as rash or skin ulcers, according to a new report...
More Medical Lab Tests Will Soon Face Federal Scrutiny, FDA Says
Laboratory tests used by millions of Americans are soon to be classified as medical devices, and as such be regulated by U.S. Food and Drug Administration,...
Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
More intensive hypertensive therapy significantly reduces the excess risk for cardiovascular disease (CVD) events associated with earlier hypertension...
Multisite QI Collaborative Increases Appropriate Pediatric Antibiotic Use
A multisite collaborative increases appropriate antibiotic use for pediatric community-acquired pneumonia, skin and soft tissue infections, and urinary...
Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
For patients with metastatic pheochromocytomas and paragangliomas (MPPGs), an antiangiogenic multi-tyrosine kinase inhibitor, cabozantinib, is promising,...
FDA Says First Round of Tests Show No Live Virus in Pasteurized Milk
Live bird flu virus has not been found in any of the first batch of retail milk samples tested, federal health officials said Friday. Amid an ongoing...
King Charles Returns to Duties After Cancer Treatment
Britain's King Charles III is back to resuming his royal duties following treatment for cancer, Buckingham Palace announced Friday. "His Majesty The King...
Biden Administration Delays Menthol Cigarette Ban
A long-awaited ban on menthol cigarettes has been delayed indefinitely, the Biden administration said Friday. “This rule has garnered historic attention,...
Lower Dose of Mpox Vaccine is Safe and Generates Six-Week Antibody Response Equivalent to Standard Regimen
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six...
Which Patients and Surgeries Are 'High Risk' for Seniors?
Most seniors probably view any emergency surgery with a certain level of anxiety. Now, a new study seeks to sort out who might be at highest risk for...
Analysis Identifies 50 New Genomic Regions Associated with Kidney Cancer Risk
In a new analysis of genetic susceptibility to kidney cancer, an international team of researchers has identified 50 new areas across the genome that are...
Dr. Reddy’s Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-Potency
Hyderabad India and Princeton, NJ, US; April 23, 2024 – Dr. Reddy's Laboratories Ltd. today announced that it is voluntarily recalling six (6) lots...
Recently Added
Recently added consumer and prescribing information: Pivya, Xromi, Risvan, Voydeya, Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist used for the treatment of WHIM syndrome.
- Beqvez Beqvez (fidanacogene elaparvovec-dzkt) is an adeno-associated virus vector-based gene therapy for the treatment of adults with moderate to...
- Pivya Pivya (pivmecillinam) is a penicillin class antibacterial for use in the treatment of uncomplicated urinary tract infections.
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
- Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.
Drug Information
Tools
- Interaction Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Community Support
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
Professionals
Top 100 Drugs
- Abilify
- Acetaminophen
- Adderall
- Alprazolam
- Amantadine
- Ambien
- Amitriptyline
- Amlodipine
- Amoxicillin
- Ativan
- Atorvastatin
- Avastin
- Azithromycin
- Baclofen
- Belsomra
- Benadryl
- Benzonatate
- Biktarvy
- Botox
- Brilinta
- Bunavail
- Buprenorphine
- Bupropion
- Buspirone
- Cephalexin
- Cetirizine
- Ciprofloxacin
- Citalopram
- Clindamycin
- Clonazepam
- Clonidine
- Cosentyx
- Cyclobenzaprine
- Cymbalta
- Dexamethasone
- Diazepam
- Diclofenac
- Doxycycline
- Duloxetine
- Dupixent
- Eliquis
- Enbrel
- Entyvio
- Epclusa
- Ezetimibe
- Famotidine
- Farxiga
- Fluoxetine
- Furosemide
- Gabapentin
- Humira
- Hydrochlorothiazide
- Hydrocodone
- Hydroxyzine
- Ibuprofen
- Januvia
- Jardiance
- Keytruda
- Klonopin
- Levothyroxine
- Lexapro
- Lisinopril
- Loratadine
- Lorazepam
- Losartan
- Lyrica
- Meloxicam
- Metformin
- Methadone
- Methocarbamol
- Methotrexate
- Metoprolol
- Metronidazole
- Miralax
- Mirtazapine
- Mounjaro
- Mucinex
- Naloxone
- Naltrexone
- Naproxen
- Omeprazole
- Opdivo
- Ondansetron
- Otezla
- Oxycodone
- Ozempic
- Pantoprazole
- Penicillin
- Percocet
- Phentermine
- Plan B
- Praluent
- Prednisone
- Prolia
- Promethazine
- Propranolol
- Prozac
- Qulipta
- Repatha
- Restasis
- Rexulti
- Rytary
- Seroquel
- Sertraline
- Sildenafil
- Sinemet
- Skyrizi
- Spironolactone
- Stelara
- Sublocade
- Suboxone
- Subutex
- Taltz
- Tamsulosin
- Tizanidine
- Toradol
- Toujeo
- Tramadol
- Trazodone
- Trelegy
- Trintellix
- Tylenol
- Ubrelvy
- Valium
- Vascepa
- Venlafaxine
- Verzenio
- Viagra
- Vivitrol
- Vraylar
- Vyvanse
- Wellbutrin
- Xanax
- Xolair
- Zetia
- Zoloft
- Zyrtec
